Abiopharma

🔍 Campion Andrew (Director)

Company: WILLIAMS SONOMA INC (WSM)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 151 shares of Deferred Stock Units (Derivative)
  Date: 2026-05-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 151.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Each deferred stock unit represents a contingent right to receive one share of WSM common stock.
• F2: The reporting person elected to receive these deferred stock units, which were granted under the Issuer's 2001 Long-Term Incentive Plan, pursuant to the Issuer's Director Compensation Policy (the "Policy"), in lieu of the cash portion of the annual retainers under the Policy.
• F3: The deferred stock units are fully vested and will be delivered to the reporting person in June 2029, the end of the deferral period, subject to earlier delivery upon the occurrence of certain events.